Latest Insider Transactions at Steris PLC (STE)
This section provides a real-time view of insider transactions for Steris PLC (STE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STERIS plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STERIS plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2022
|
Jacqueline B Kosecoff Director |
SELL
Open market or private sale
|
Direct |
3,218
-100.0%
|
$756,230
$235.2 P/Share
|
|
Feb 10
2022
|
Jacqueline B Kosecoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,218
+50.0%
|
$102,976
$32.36 P/Share
|
|
Dec 23
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
30,000
-39.24%
|
$7,200,000
$240.0 P/Share
|
|
Dec 23
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+28.18%
|
$2,070,000
$69.72 P/Share
|
|
Dec 02
2021
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-5.03%
|
$27,720
$220.63 P/Share
|
|
Dec 02
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
333
+11.73%
|
-
|
|
Nov 15
2021
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
1,950
-13.31%
|
$452,400
$232.97 P/Share
|
|
Oct 22
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
20,000
-30.1%
|
$4,700,000
$235.0 P/Share
|
|
Oct 22
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+23.14%
|
$1,340,000
$67.98 P/Share
|
|
Oct 11
2021
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
149
-6.42%
|
$32,929
$221.54 P/Share
|
|
Oct 11
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
506
+17.89%
|
-
|
|
Oct 07
2021
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-8.97%
|
$38,843
$217.33 P/Share
|
|
Oct 07
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
607
+23.33%
|
-
|
|
Oct 01
2021
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
344
+5.12%
|
-
|
|
Oct 01
2021
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,156
+3.5%
|
-
|
|
Oct 01
2021
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
692
+11.25%
|
-
|
|
Oct 01
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Sale (or disposition) back to the issuer
|
Direct |
121
-1.88%
|
$27,588
$228.36 P/Share
|
|
Oct 01
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
576
+8.22%
|
-
|
|
Oct 01
2021
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
692
+4.51%
|
-
|
|
Oct 01
2021
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
344
+5.68%
|
-
|
|
Oct 01
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
576
+1.23%
|
-
|
|
Oct 01
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Grant, award, or other acquisition
|
Direct |
1,156
+45.44%
|
-
|
|
Oct 01
2021
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
808
+2.54%
|
-
|
|
Aug 26
2021
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Open market or private sale
|
Direct |
1,449
-21.24%
|
$308,637
$213.63 P/Share
|
|
Aug 26
2021
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,449
+6.77%
|
$126,063
$87.0 P/Share
|
|
Aug 13
2021
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
11,000
-15.62%
|
$2,398,000
$218.56 P/Share
|
|
Aug 13
2021
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+28.61%
|
-
|
|
Aug 10
2021
|
Nirav R Shah Director |
SELL
Payment of exercise price or tax liability
|
Direct |
208
-41.6%
|
$45,136
$217.62 P/Share
|
|
Aug 10
2021
|
Nirav R Shah Director |
BUY
Grant, award, or other acquisition
|
Direct |
500
+50.0%
|
-
|
|
Jul 21
2021
|
David B Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,561
+15.92%
|
$48,391
$31.61 P/Share
|
|
Jun 02
2021
|
Richard C Breeden Director |
BUY
Grant, award, or other acquisition
|
Direct |
160
+0.46%
|
-
|
|
Jun 02
2021
|
Christopher S Holland Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+9.46%
|
-
|
|
Jun 02
2021
|
Andrew Xilas SVP and GM, Dental |
BUY
Grant, award, or other acquisition
|
Direct |
232
+50.0%
|
-
|
|
Jun 02
2021
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,056
+16.48%
|
-
|
|
Jun 02
2021
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
3,276
+9.78%
|
-
|
|
Jun 02
2021
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
1,964
+11.61%
|
-
|
|
Jun 02
2021
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
784
+11.5%
|
-
|
|
Jun 02
2021
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,836
+27.81%
|
-
|
|
Jun 02
2021
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
576
+9.68%
|
-
|
|
Jun 02
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+19.73%
|
-
|
|
Jun 02
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,292
+4.76%
|
-
|
|
Jun 01
2021
|
Daniel A Carestio President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,677
-6.37%
|
$315,276
$188.43 P/Share
|
|
Jun 01
2021
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,945
-6.73%
|
$365,660
$188.43 P/Share
|
|
Jun 01
2021
|
Cary L Majors SVP and President, Healthcare |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,129
-14.08%
|
$400,252
$188.43 P/Share
|
|
Jun 01
2021
|
Karen L Burton VP & CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
897
-14.6%
|
$168,636
$188.43 P/Share
|
|
Jun 01
2021
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
234
-7.4%
|
$43,992
$188.43 P/Share
|
|
Jun 01
2021
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
133
-2.7%
|
$25,004
$188.43 P/Share
|
|
Jun 01
2021
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Sale (or disposition) back to the issuer
|
Direct |
224
-1.23%
|
$42,112
$188.43 P/Share
|
|
Jun 01
2021
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,946
-4.27%
|
$365,848
$188.43 P/Share
|
|
May 27
2021
|
Richard C Breeden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,121
+8.23%
|
$96,751
$31.61 P/Share
|